Citizens Business Bank Amgen Inc Transaction History

Citizens Business Bank

$466 Million
Q1 2024

A detailed history of Citizens Business Bank transactions in Amgen Inc stock. As of the latest transaction made, Citizens Business Bank holds 2,247 shares of AMGN stock, worth $709,849. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,247

Previous 2,247 -0.0%

Holding current value

$709,849

Previous $647,000 1.39%

% of portfolio

0.14%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $84,381 - $95,191	-330 Reduced 12.81%	2,247 $647,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $74,434 - $94,578	-325 Reduced 11.2%	2,577 $676,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $651,382 - $734,641	2,902 New	2,902 $654,000
Q2 2022 Nov 18, 2022	BUY	$230.71 - $256.74 $103,127 - $114,762	447 Added 6.04%	7,849 $1.91 Million
Q4 2021 Nov 18, 2022	BUY	$198.88 - $227.6 $19,888 - $22,760	100 Added 1.37%	7,402 $1.67 Million

Q1 2021 Nov 18, 2022	SELL	$221.91 - $258.6 $636,881 - $742,182	-2,870 Reduced 28.21%	7,302 $1.82 Million
Q4 2020 Nov 18, 2022	SELL	$216.38 - $257.67 $349,237 - $415,879	-1,614 Reduced 13.69%	10,172 $2.34 Million
Q3 2020 Nov 18, 2022	SELL	$234.65 - $260.95 $23,465 - $26,095	-100 Reduced 0.84%	11,786 $3 Million
Q2 2020 Nov 18, 2022	BUY	$197.81 - $242.74 $60,134 - $73,792	304 Added 2.62%	11,886 $2.8 Million
Q1 2020 Nov 18, 2022	BUY	$182.24 - $241.7 $34,990 - $46,406	192 Added 1.69%	11,582 $2.35 Million
Q4 2019 Nov 18, 2022	SELL	$189.21 - $243.2 $7,000 - $8,998	-37 Reduced 0.32%	11,390 $2.75 Million
Q3 2019 Nov 18, 2022	SELL	$174.11 - $208.62 $376,774 - $451,453	-2,164 Reduced 15.92%	11,427 $2.21 Million
Q2 2019 Nov 18, 2022	BUY	$166.7 - $195.41 $957,858 - $1.12 Million	5,746 Added 73.24%	13,591 $2.51 Million
Q1 2019 Nov 18, 2022	BUY	$180.87 - $203.88 $322,310 - $363,314	1,782 Added 29.39%	7,845 $1.49 Million
Q4 2018 Nov 18, 2022	BUY	$178.4 - $208.25 $499,520 - $583,100	2,800 Added 85.81%	6,063 $1.18 Million
Q3 2018 Nov 18, 2022	SELL	$185.29 - $208.89 $12,970 - $14,622	-70 Reduced 2.1%	3,263 $676,000
Q2 2018 Nov 18, 2022	BUY	$166.05 - $186.51 $16,771 - $18,837	101 Added 3.13%	3,333 $615,000
Q1 2018 Nov 18, 2022	SELL	$169.43 - $198.0 $6,777 - $7,920	-40 Reduced 1.22%	3,232 $551,000
Q4 2017 Nov 18, 2022	BUY	$168.79 - $188.59 $16,879 - $18,859	100 Added 3.15%	3,272 $569,000
Q3 2017 Nov 18, 2022	SELL	$167.29 - $191.0 $8,364 - $9,550	-50 Reduced 1.55%	3,172 $591,000
Q2 2017 Nov 18, 2022	BUY	N/A	320 Added 11.03%	3,222 $555,000
Q4 2016 Nov 18, 2022	BUY	N/A	400 Added 14.17%	3,222 $471,000
Q3 2016 Nov 18, 2022	SELL	N/A	-79 Reduced 2.72%	2,822 $471,000
Q2 2016 Nov 18, 2022	BUY	N/A	129 Added 4.65%	2,901 $441,000
Q1 2016 Nov 18, 2022	BUY	N/A	2,772 New	2,772 $416,000
Q4 2015 Nov 18, 2022	SELL	N/A	-2,272 Closed	0 $0
Q3 2015 Nov 18, 2022	BUY	N/A	2,272 New	2,272 $314,000
Q3 2013 Nov 18, 2022	SELL	N/A	-4,600 Closed	0 $0
Q2 2013 Nov 18, 2022	SELL	N/A	-1,000 Reduced 17.86%	4,600 $454,000
Q1 2013 Nov 18, 2022	SELL	N/A	-7,500 Reduced 57.25%	5,600 $574,000
Q4 2012 Nov 18, 2022	BUY	N/A	10,198	13,100 $1.13 Million

Others Institutions Holding AMGN

# of Institutions

2,936

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Account

Citizens Business Bank Amgen Inc Transaction History